In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher.
The Innovation and Value Initiative (IVI), a nonprofit research organization committed to advancing the science, practice, and use of value assessment in health care, today announced a collaboration with the University of Southern California Leonard D. Schaeffer Center for Health Policy & Economics to examine treatment patterns and disparities for children and young adults newly diagnosed with major depressive disorder (MDD).
In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher. The symptoms of childhood and adolescence depression can include academic decline, withdrawal, unexpected crying, weight changes, and thoughts or actions of self-harm. All too often, depression goes undiagnosed and untreated in this vulnerable population.
Bringing together health policy experts and a seasoned health economics and outcomes research (HEOR) team, this partnership will focus on:
“The USC Schaeffer Center partnership provides a meaningful opportunity to learn how COVID-19 and the broader access to telehealth services has affected health care outcomes and disparities,” noted Rick Chapman, PhD, chief science officer at IVI. “Our goal is to close the gaps and better inform health care outcomes for children and adolescents with major depressive disorder.”
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More